Table 1.
Baseline characteristics of patients with lacrimal gland carcinoma
| Total (n = 18) | Patient number | Percentage (%) |
|---|---|---|
| Median age (years) | 54 (20–85) | |
| Sex | ||
| Male | 8 | 44.4 |
| Female | 10 | 55.6 |
| T stage | ||
| 1 | 1 | 5.6 |
| 2 | 9 | 50.0 |
| 3 | 3 | 16.7 |
| 4 | 5 | 27.7 |
| Types of surgery | ||
| Excision | 15 | 83.3 |
| Needle biopsy | 3 | 16.7 |
| RT treatment | ||
| Adjuvant RT alone | 13 | 72.2 |
| Adjuvant CCRT | 2 | 11.1 |
| Definitive RT | 2 | 11.1 |
| Definitive CCRT | 1 | 5.6 |
| RT type | ||
| 3DCRT | 2 | 11.1 |
| IMRT | 14 | 77.8 |
| Proton | 2 | 11.1 |
| RT dose | ||
| < 6600 cGy | 9 | 50.0 |
| ≥ 6600 cGy | 9 | 50.0 |
| Cell type | ||
| Adenoid cystic carcinoma | 9 | 50.0 |
| Carcinoma ex pleomorphic adenoma | 7 | 38.9 |
| Poorly differentiated adenocarcinoma | 2 | 11.1 |
| Margin | ||
| positive | 13 | 72.2 |
| negative | 5 | 27.8 |
| LVSI | ||
| Positive | 6 | 33.3 |
| Negative | 12 | 66.7 |
| PNI | ||
| Positive | 8 | 44.4 |
| Negative | 10 | 55.6 |
RT radiotherapy, CCRT concurrent chemoradiotherapy, 3DCRT 3-dimensional conformal radiotherapy, IMRT intensity-modulated radiotherapy, cGy centigray, LVSI lymphovascular invasion, PNI perineural invasion.